Zevra to Report 2024 Fourth Quarter and Full Year Financial Results

Core Viewpoint - Zevra Therapeutics, Inc. will report its corporate and financial results for Q4 and full year 2024 on March 11, 2025, and will host a conference call at 4:30 p.m. ET on the same day [1]. Group 1 - The company focuses on providing therapies for individuals with rare diseases, aiming to create transformational therapies where limited or no treatment options exist [3]. - Zevra employs unique, data-driven development and commercialization strategies to address complex drug development challenges [3]. - A link to the audio webcast of the conference call will be available on the "Events & Presentations" page of Zevra's website [2]. Group 2 - A replay of the conference call will be accessible for 90 days starting approximately at 5:30 p.m. ET on the same day [2]. - For further information, Zevra's website and social media platforms can be visited [4]. - Contact information for inquiries is provided, including a dedicated conference ID for the call [6].